FDA Advisory Committee Unanimously Recommends Approval of Genzyme's (GENZ) Synvisc-One
Tweet Send to a Friend
Genzyme Corporation (Nasdaq: GENZ) announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


